Establishment Labs Stock Forecast, Price & News

Establishment Labs' stock was trading at $15.15 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ESTA shares have increased by 242.6% and is now trading at $51.90.
View which stocks have been most impacted by COVID-19.

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Establishment Labs stock.
View analyst ratings for Establishment Labs or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Establishment Labs a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Establishment Labs wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Establishment Labs is scheduled to release its next quarterly earnings announcement on Monday, March 15th 2021.
View our earnings forecast for Establishment Labs.

Establishment Labs Holdings Inc. (NASDAQ:ESTA) announced its quarterly earnings data on Monday, November, 9th. The company reported ($0.18) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($0.30) by $0.12. The firm earned $22.76 million during the quarter, compared to analysts' expectations of $22.50 million. Establishment Labs had a negative net margin of 46.40% and a negative trailing twelve-month return on equity of 49.51%.
View Establishment Labs' earnings history.

Establishment Labs updated its fourth quarter 2020 Pre-Market earnings guidance on Monday, January, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $26.5-27.5 million, compared to the consensus revenue estimate of $23.72 million.

4 brokerages have issued 1 year price targets for Establishment Labs' stock. Their forecasts range from $20.00 to $61.00. On average, they expect Establishment Labs' stock price to reach $31.75 in the next year. This suggests that the stock has a possible downside of 38.8%.
View analysts' price targets for Establishment Labs or view Wall Street analyst' top-rated stocks.

Some companies that are related to Establishment Labs include Avanos Medical (AVNS), Eargo (EAR), Inogen (INGN), Invacare (IVC), Sanara MedTech (SMTI), Sientra (SIEN), Lakeland Industries (LAKE), United Health Products (UEEC), Alpha Pro Tech (APT), Milestone Scientific (MLSS), Surgalign (SRGA), Conformis (CFMS), Nutriband (NTRB), CollPlant Biotechnologies (CLGN) and ReWalk Robotics (RWLK).
View all of ESTA's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

(ESTA) raised $50 million in an initial public offering (IPO) on Thursday, July 19th 2018. The company issued 3,100,000 shares at $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

Establishment Labs' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Ritholtz Wealth Management (0.04%). Company insiders that own Establishment Labs stock include David L Bonvenuto, Jw Asset Management, Llc, Mezerville Roberto De, Nicholas Sheridan Lewin, Quiros Juan Jose Chacon and Santos Salvador Dada.
View institutional ownership trends for Establishment Labs.

ESTA stock was bought by a variety of institutional investors in the last quarter, including Ritholtz Wealth Management. Company insiders that have bought Establishment Labs stock in the last two years include David L Bonvenuto, Jw Asset Management, Llc, Mezerville Roberto De, and Nicholas Sheridan Lewin.
View insider buying and selling activity for Establishment Labs or or view top insider-buying stocks.

Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ESTA stock can currently be purchased for approximately $51.90.

Establishment Labs has a market capitalization of $1.22 billion and generates $89.57 million in revenue each year. The company earns $-38,150,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis. Establishment Labs employs 602 workers across the globe.

The official website for Establishment Labs is www.establishmentlabs.com.

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at 506 2434 2400 or via email at [email protected]